@dan_soffer

Internist and lipidologist at University of Pennsylvania. Aging soccer player. Dad and husband. President National Lipid Association (2023/24)

Joined June 2015
  • Tweets2.7K
  • Following586
  • Followers1.3K
134Media
Dan Soffer retweeted
Circulation@CircAHA1 Oct 2024
#OriginalResearch Both 'weekend warrior' and regular exercise patterns lower cardiometabolic risk. The total volume of physical activity, rather the pattern is most relevant for risk of future disease. @ShinoKany @shaan_khurshid ahajournals.org/doi/abs/10.1…
31
4
90
19,308
A timely symposium on Racial Disparities in Cardiovascular Disease Risk sponsored by @UABCardiology Honored to be invited My talk will be on ‘Race and cardiovascular risk. Is it genes or environment?’
UAB Cardiovascular Disease@UABCardiology1 Oct 2024
Replying to @UABCardiology
Session 2: Racial Disparities in Cardiovascular Disease Risk Iftikhar J. Kullo, MD - Mayo Clinic Topic: Race and cardiovascular risk. Is it genes or environment? Time: 10:35 - 11:00 AM
5
23
2,321
Save these dates for #EpiLifestyle25! New Orleans is the place to be for insightful discussions, leading epidemiology and lifestyle science, and networking with colleagues old and new.
6
1
14
4,369
Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System. @dan_soffer authors.elsevier.com/a/1jn5T…
5
3
16
2,593
Real-world experience of inclisiran at UPenn, now in JCL: authors.elsevier.com/a/1jpv%… @dan_soffer @MWilkinsonMD
1
3
407
Join us for Beyond the Basics: Approach to Lipoprotein(a) Management, a complimentary dinner program with CVI and PLAC! October 16, at the Loews Philadelphia Hotel. tinyurl.com/6ym2jve9
4
8
841
In this @medscapeCME, #CardioRheumatology experts Dr. Michael Garshick and Dr. Brittany Weber share insights on assessing inflammatory risk and the latest treatments to improve outcomes for patients at risk of cardiovascular events. @nyugrossman @RobMagyar @garshick @Bweber04
Medscape Education@MedscapeCME11 Sep 2024
Identifying residual inflammatory risk is crucial for developing targeted treatments to reduce future CV events and manage atherosclerosis more effectively! Watch @garshick + @Bweber04 explain the ASCVD / inflammation / CKD nexus 👉 ms.spr.ly/6010m3kok
6
1
17
3,152
Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System, JCL in press. kwnsfk27.r.eu-west-1.awstrac…
3
2
19
1,460
Now available @nationallipid @MarlysLPA @MBBoffa @Lpa_Doc @hillypaige2 @PennCVFellows @PennCardiology @ProfKausikRay @JohnKastelein @ArsenaultBenoit @Drlipid
4
390
Thanks Dr. Kulkarni for the opportunity. It’s always fun to write about lipids :)
Anandita Kulkarni, MD FACC@AKulkarniMD13 Sep 2024
So proud of my superstar fellow @PriyaPillaiMD of @HeartPlano for expertly curating this Tweetorial on dietary habits! Please be sure to check it out! @PSatishMD @carolkirkpat3 @AnumSaeedMD @amehta_09 @LipidCNS @nationallipid
1
2
354
📄#SourceSaturday: Our Practical Recommendations in the Management of CV Diseases Check out this easy breakdown! 🔗Download the infographic ow.ly/ZyaE50TnaFA #LipidXcellence #CholesterolMonth
3
9
882
We’re just 10 DAYS away from thought-provoking sessions and impactful discussion at the #FamilyHeartSummit24. Wave hi if we’ll see you there! 👋
1
2
364
I have had the pleasure of working with @TinaKReddy and team to highlight the importance of public health measures and team-based care in addressing the disproportionate burden of resistant hypertension in US Black adults. See our article here! link.springer.com/article/10…
2
14
718
Lipidaholics - just what you are all waiting for - another podcast of yours truly - this time interviewed by a pharmacist, Dr Tamara Ruggles - As usual I had a lot of fun - Visit and hopefully enjoy at https:// pharmacypodcastnetwork.podbe… @nationallipid @society_eas @escardio @atherosociety @TheFHFoundation

The Lipid Lowdown | Geriatric Pharmacy Focus | Pharmacy Podcast...

This podcast delves into coronary artery calcium (CAC) scores, the use of statins, a simple method to determine whether you produce or absorb too much cholesterol, whether LDL can be too low, key lab...

pharmacypodcastnetwork.podbean.com
2
7
38
3,763
Anne Langsted and I wrote a quick and comprehensive ABC on "Lipoprotein(a) and cardiovascular disease", just published in The Lancet: thelancet.com/journals/lance… As 1 in 5 have this the most common genetic cause of CVD, it is high time to measure in all at CVD risk. Treatment soon:
9
58
6
167
23,421
@nationallipid recently made recommendations to consider lipoprotein apheresis in certain patients with elevated Lp(a): sciencedirect.com/science/ar… @MarlysLPA @MBBoffa @kcferdmd @ErinMichos @DrSafarova @dan_soffer @PamTaubMD @CBallantyneMD @grsoffer @hsbhatia @DrMichaelShapir
3
9
23
921
Lp(a) is actionable today, & for some patients this includes treatment with lipoprotein apheresis link.springer.com/article/10… @MBBoffa @MarlysLPA @kcferdmd @ErinMichos @DrSafarova @nationallipid @ASPCardio @dan_soffer @CBallantyneMD @PamTaubMD @DrMichaelShapir @lipiddoc @UCSDHealth
4
11
548
Dear Twitter/X, thank you for noticing our apoB paper. In an effort to release it coincident with our Fall CLU, the infographic draft was inadvertently released. Please keep an eye out for the final product and apologies for the miscommunication. Thanks for the feedback!
4
1
9
3,637
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association - Journal of Clinical Lipidology lipidjournal.com/article/S19…

Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert...

Summary of key points

lipidjournal.com
9
1
46
3,305
📚#SpotlightSunday Dive into the essentials w/ the 2018 Guidelines for Managing Blood Cholesterol They provide clear, actionable steps to manage cholesterol levels & reduce CV risk in your patients Read the guidelines🔗ow.ly/wuZK50TaZfQ #LipidXcellence #CholesterolMonth
1
1
4
806
Load more